A novel Pim-1 kinase-targeted photosensitizer to combat triple-negative breast cancer with enhanced photodynamic efficacy and reduced metastasis
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer Mechanisms and Therapy · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (62)
Show source-provided references
1. Breast cancer10.1038/s41572-019-0111-2 ↗
2. Breast cancer10.1016/S0140-6736(16)31891-8 ↗
3. Triple negative breast cancer: emerging therapeutic modalities and novel combination therapies10.1016/j.ctrv.2017.11.003 ↗
4. Dissecting the heterogeneity of triple-negative breast cancer10.1200/JCO.2011.38.2010 ↗
5. Triple-negative breast cancer: epidemiological considerations and recommendations10.1093/annonc/mds187 ↗
6. Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity10.1002/cncr.25961 ↗
7. Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer10.1039/D0NR00523A ↗
8. Molecular targeting of RRM2, NF-κB, and mutant TP53 for the treatment of triple-negative breast cancer10.1158/1535-7163.MCT-20-0373 ↗
9. A novel thienopyrimidine analog, TPH104, mediates immunogenic cell death in triple-negative breast cancer cells10.3390/cancers13081954 ↗
10. Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study10.1093/annonc/mdt556 ↗
11. Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy10.1126/scitranslmed.aao1641 ↗
12. A phase I/II trial of olaparib tablet in combination with eribulin in Japanese patients with advanced or metastatic triple-negative breast cancer previously treated with anthracyclines and taxanes10.1016/j.ejca.2018.11.014 ↗
13. Chemotherapy use and surgical treatment by receptor subtype in node-negative T1a and T1b female breast cancers, Iowa SEER Registry, 2010 to 201210.1016/j.clbc.2014.07.009 ↗
14. (64)Cu/(177)Lu-DOTA-diZD, a small-molecule-based theranostic pair for triple-negative breast cancer10.1021/acs.jmedchem.0c01957 ↗
15. Small-molecule drug discovery in triple negative breast cancer: current situation and future directions10.1021/acs.jmedchem.0c01180 ↗
16. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial10.1038/s41591-019-0432-4 ↗
17. Smart gold nanocages for mild heat-triggered drug release and breaking chemoresistance10.1016/j.jconrel.2020.04.029 ↗
18. Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies10.1016/j.ejmech.2015.07.010 ↗
19. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
20. Phthalocyanines as medicinal photosensitizers: developments in the last five years10.1016/j.ccr.2017.08.003 ↗
21. Photodynamic therapy induces autophagy-mediated cell death in human colorectal cancer cells via activation of the ROS/JNK signaling pathway10.1038/s41419-020-03136-y ↗
22. Bioinspired hybrid protein oxygen nanocarrier amplified photodynamic therapy for eliciting anti-tumor immunity and abscopal effect10.1021/acsnano.8b04371 ↗
23. Fibronectin-targeting and cathepsin B-activatable theranostic nanoprobe for MR/fluorescence imaging and enhanced photodynamic therapy for triple negative breast cancer10.1021/acsami.0c10397 ↗
24. Bright aggregation-induced emission nanoparticles for two-photon imaging and localized compound therapy of cancers10.1021/acsnano.0c05610 ↗
25. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy10.1039/C6CS00271D ↗
26. Photodynamic therapy mediated by nontoxic core-shell nanoparticles synergizes with immune checkpoint blockade to elicit antitumor immunity and antimetastatic effect on breast cancer10.1021/jacs.6b09538 ↗
27. A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy10.1038/sj.bjc.6602953 ↗
28. Hollow MnO(2) as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses10.1038/s41467-017-01050-0 ↗
29. Sheddable prodrug vesicles combating adaptive immune resistance for improved photodynamic immunotherapy of cancer10.1021/acs.nanolett.9b04012 ↗
30. Acid-activatable versatile micelleplexes for PD-L1 blockade-enhanced cancer photodynamic immunotherapy10.1021/acs.nanolett.6b01994 ↗
31. Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation10.1039/D0NH00480D ↗
32. Photodynamic activity of vitamin-chlorin conjugates at nanomolar concentrations against triple-negative breast cancer cells10.1021/acsomega.8b02323 ↗
33. Catch and release photosensitizers: combining dual-action ruthenium complexes with protease inactivation for targeting invasive cancers10.1021/jacs.8b08853 ↗
34. A redox-responsive theranostic agent for target-specific fluorescence imaging and photodynamic therapy of EGFR-overexpressing triple-negative breast cancers10.1039/C6TB01519K ↗
35. Nanostructured phthalocyanine assemblies with protein-driven switchable photoactivities for biophotonic imaging and therapy10.1021/jacs.7b05916 ↗
36. PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer10.1038/nm.4198 ↗
37. PIM-1 kinase: a potential biomarker of triple-negative breast cancer10.2147/OTT.S212752 ↗
38. PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression10.1038/nm.4213 ↗
39. PIM-1 kinase: a potential biomarker of triple-negative breast cancer10.2147/OTT.S212752 ↗
40. Discovery of novel pyrazolo[3,4-b]pyridine scaffold-based derivatives as potential PIM-1 kinase inhibitors in breast cancer MCF-7 cells10.1016/j.bmc.2020.115828 ↗
41. Discovery of (R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4- b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3 H)-one, a potent and selective pim-1/2 kinase inhibitor for hematological malignancies10.1021/acs.jmedchem.8b01733 ↗
42. Pim kinase inhibitors in cancer: medicinal chemistry insights into their activity and selectivity10.1016/j.drudis.2020.09.017 ↗
43. PIM kinase inhibitors: structural and pharmacological perspectives10.1016/j.ejmech.2019.03.050 ↗
44. The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer10.1039/C9CS00129H ↗
45. Highly selective red-emitting fluorescent probe for imaging cancer cells in situ by targeting pim-1 kinase10.1021/acsami.7b14553 ↗
46. A novel zinc phthalocyanine-indometacin photosensitizer with “Three-in-one” cyclooxygenase-2-driven dual targeting and aggregation inhibition for high-efficient anticancer therapy10.1016/j.dyepig.2021.109997 ↗
47. A phthalocyanine-based photosensitizer for effectively combating triple negative breast cancer with enhanced photodynamic anticancer activity and immune response10.1016/j.ejmech.2022.114644 ↗
48. Highly selective red-emitting fluorescent probe for imaging cancer cells in situ by targeting pim-1 kinase10.1021/acsami.7b14553 ↗
49. Photophysical studies of newly derivatized mono substituted phthalocyanines grafted onto silica nanoparticles via click chemistry10.1016/j.saa.2014.12.070 ↗
50. A molecular combination of zinc(II) phthalocyanine and tamoxifen derivative for dual targeting photodynamic therapy and hormone therapy10.1021/acs.jmedchem.7b00682 ↗
51. Glutathione-activated DNA-Au nanomachine as targeted drug delivery platform for imaging-guided combinational cancer therapy10.1016/j.cej.2021.129535 ↗
52. An open source and reduce expenditure ROS generation strategy for chemodynamic/photodynamic synergistic therapy10.1038/s41467-020-15591-4 ↗
53. Activatable singlet oxygen generation from lipid hydroperoxide nanoparticles for cancer therapy10.1002/anie.201701181 ↗
54. Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer10.1016/j.jconrel.2020.02.043 ↗
55. Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release10.1186/1743-8977-11-11 ↗
56. A pH-sensitive self-assembled and carrier-free nanoparticle based on charge reversal for enhanced synergetic chemo-phototherapy
57. A singlet oxygen self-reporting photosensitizer for cancer phototherapy10.1039/D0SC05495J ↗
58. EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer10.7150/thno.57706 ↗
59. Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer10.1186/s13045-021-01052-y ↗
60. Bioinspired hybrid protein oxygen nanocarrier amplified photodynamic therapy for eliciting anti-tumor immunity and abscopal effect10.1021/acsnano.8b04371 ↗
61. Oxygen-independent free radical generation mediated by core-shell magnetic nanocomposites synergizes with immune checkpoint blockade for effective primary and metastatic tumor treatment10.1016/j.nantod.2020.101024 ↗
62. Fucoidan-based, tumor-activated nanoplatform for overcoming hypoxia and enhancing photodynamic therapy and antitumor immunity10.1016/j.biomaterials.2020.120227 ↗